Xiangpeng Dai Selected Research

Xiangpeng Dai Research Topics

Disease

31	Neoplasms (Cancer) 06/2023 - 05/2014
13	Carcinogenesis 01/2022 - 04/2014
8	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 09/2015
6	Melanoma (Melanoma, Malignant) 01/2022 - 08/2013
3	Breast Neoplasms (Breast Cancer) 06/2023 - 01/2020
3	Triple Negative Breast Neoplasms 01/2023 - 01/2020
3	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2017
2	Body Weight (Weight, Body) 04/2024 - 11/2022
2	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 06/2023
2	Neuroblastoma 01/2023 - 01/2022
2	Leukemia 01/2020 - 09/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024
1	Stomach Neoplasms (Stomach Cancer) 01/2024
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Inflammation (Inflammations) 11/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Food Hypersensitivity (Food Allergy) 01/2022
1	Dermatitis 01/2022
1	Deficiency Diseases (Deficiency Disease) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Nevus (Nevi) 12/2018
1	Alzheimer Disease (Alzheimer's Disease) 10/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2018
1	Starvation 01/2018
1	Pathologic Processes 01/2018
1	Carcinoma (Carcinomatosis) 05/2016
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 05/2014

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2016
6	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 05/2014
5	Cullin Proteins (Cullins)IBA 01/2023 - 01/2017
5	Ligases (Synthetase)IBA 01/2023 - 04/2014
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021 - 09/2015
4	Phosphotransferases (Kinase)IBA 01/2021 - 12/2015
3	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2021
3	UbiquitinIBA 01/2023 - 04/2014
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 04/2024 - 11/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2022
2	Disulfiram (Antabuse)FDA Link 01/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2021
2	Thioguanine (Tioguanine)FDA Link 01/2022 - 01/2020
2	Histones (Histone)IBA 01/2022 - 05/2016
2	CyclinsIBA 07/2019 - 01/2018
1	Streptozocin (Streptozotocin)FDA Link 04/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2024
1	Nicotinamide MononucleotideIBA 04/2024
1	T-Lymphoma Invasion and Metastasis-inducing Protein 1IBA 01/2024
1	disulfiram-copperIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	CopperIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	VaccinesIBA 01/2023
1	Protein Subunit VaccinesIBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 11/2022
1	Sirtuin 1IBA 01/2022
1	Proto-Oncogene Proteins B-rafIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	CRISPR-Associated Protein 9IBA 01/2021
1	Dynamins (Dynamin)IBA 12/2020
1	Deubiquitinating EnzymesIBA 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	6-methyladenineIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 10/2018
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	LigandsIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Histone Deacetylase 6IBA 07/2017
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 07/2017
1	pevonedistatIBA 07/2017
1	bafilomycin A1IBA 07/2017
1	Proteasome InhibitorsIBA 07/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2017
1	Cyclin D1IBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	TransferasesIBA 05/2016
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 05/2016
1	MethyltransferasesIBA 12/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015
1	PAX3 Transcription FactorIBA 09/2015
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2015
1	EnzymesIBA 01/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2015
1	Small Interfering RNA (siRNA)IBA 05/2014
1	Antimitotic AgentsIBA 05/2014
1	Antineoplastic Agents (Antineoplastics)IBA 05/2014
1	Anaphase-Promoting Complex-CyclosomeIBA 04/2014
1	Type 1 Melanocortin ReceptorIBA 08/2013

Therapy/Procedure

10	Therapeutics 06/2023 - 01/2017
7	Immunotherapy 03/2024 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Molecular Targeted Therapy 01/2022
1	Oncolytic Virotherapy 01/2021